WHO ICTRP trial
The effect of 1.25 dihydroxy vitamin D on IMT, iron indicators changes induced…
IRCT201211106415N3 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201211106415N3 |
|---|---|
| Public title | The effect of 1.25 dihydroxy vitamin D on IMT, iron indicators changes induced by inflammation and inflammatory biomarkers in patients with chronic kidney disease |
| Scientific title | The effect of 1.25 dihydroxy vitamin D on IMT, iron indicators changes induced by inflammation and inflammatory biomarkers in patients with chronic kidney disease |
| Primary sponsor | Vice chancellor for research, Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Chronic Kidney Disease. Chronic kidney disease;Chronic kidney disease |
| Interventions | It is clinical trial without placebo control of 40 subjects between the ages of 45 and 75 years with chronic kidney disease. CKD patients will be confirmed (by physician) at the initial of diagnosis. The inclusion criteria comprised: Not… |
| Registration date | Mar 10, 2013 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: